Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 22442166)

1.

Statin use and the risk of Clostridium difficile in academic medical centres.

Motzkus-Feagans CA, Pakyz A, Polk R, Gambassi G, Lapane KL.

Gut. 2012 Nov;61(11):1538-42. Epub 2012 Mar 22.

2.
3.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
4.

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.

Dormuth CR, Hemmelgarn BR, Paterson JM, James MT, Teare GF, Raymond CB, Lafrance JP, Levy A, Garg AX, Ernst P; Canadian Network for Observational Drug Effect Studies.

BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.

5.

Risk of incident diabetes among patients treated with statins: population based study.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM.

BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610. Erratum in: BMJ. 2013;347:f4356.

6.

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.

Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.

Curr Med Res Opin. 2008 Jul;24(7):1987-2000. doi: 10.1185/03007990802203279 . Epub 2008 Jun 4. Erratum in: Curr Med Res Opin. 2010 Mar;26(3):631.

PMID:
18554430
7.

The burden of Clostridium difficile in surgical patients in the United States.

Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT.

Surg Infect (Larchmt). 2007 Dec;8(6):557-66. doi: 10.1089/sur.2006.062.

PMID:
18171114
8.
9.

Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.

Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE.

Pharmacotherapy. 2012 Aug;32(8):744-54. doi: 10.1002/j.1875-9114.2012.01160.x.

PMID:
23307522
10.

Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.

Pakyz AL, Jawahar R, Wang Q, Harpe SE.

J Antimicrob Chemother. 2014 Apr;69(4):1127-31. doi: 10.1093/jac/dkt489. Epub 2013 Dec 9.

11.

Clostridium difficile infection in hospitalized children in the United States.

Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB.

Arch Pediatr Adolesc Med. 2011 May;165(5):451-7. doi: 10.1001/archpediatrics.2010.282. Epub 2011 Jan 3.

PMID:
21199971
12.

Do statins protect against the development of Clostridium difficile-associated diarrhoea?

Nseir W, Bishara J, Mograbi J, Mahamid M, Khalaila W, Taha M, Farah R.

J Antimicrob Chemother. 2013 Aug;68(8):1889-93. doi: 10.1093/jac/dkt101. Epub 2013 Apr 5.

13.

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.

Expert Opin Pharmacother. 2008 Apr;9(5):669-76. doi: 10.1517/14656566.9.5.669.

PMID:
18345946
14.

Statins and cancer risk.

Karp I, Behlouli H, Lelorier J, Pilote L.

Am J Med. 2008 Apr;121(4):302-9. doi: 10.1016/j.amjmed.2007.12.011.

PMID:
18374689
15.

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

Dial S, Kezouh A, Dascal A, Barkun A, Suissa S.

CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.

16.
17.

Statin use and risk of first-time psoriasis diagnosis.

Brauchli YB, Jick SS, Meier CR.

J Am Acad Dermatol. 2011 Jul;65(1):77-83. doi: 10.1016/j.jaad.2010.05.039. Epub 2011 May 6.

PMID:
21529997
18.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142.

PMID:
15531001
19.

Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.

Rodriguez S, Hernandez MB, Tarchini G, Zaleski M, Vatanchi M, Cardona L, Castro-Pavia F, Schneider A.

Clin Gastroenterol Hepatol. 2014 Nov;12(11):1856-61. doi: 10.1016/j.cgh.2014.02.040. Epub 2014 Mar 27.

PMID:
24681079
20.

A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.

Hoffman KB, Kraus C, Dimbil M, Golomb BA.

PLoS One. 2012;7(8):e42866. doi: 10.1371/journal.pone.0042866. Epub 2012 Aug 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk